Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
US10864217B2 · kind B2 · utility
1Cited by
17References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 24, 2019 |
| Grant date | Dec 15, 2020 |
| Priority date | — |
| Expiry date | May 24, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.